EIF4G1 and non-small cell lung carcinoma: One study showed that 4EGI‐1, one of EIF4G1 inhibitors, enhanced the apoptotic effects of tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) on NSCLC cell lines, through inducing CCAAT/enhancer binding protein homologous protein‐dependent DR5 and ubiquitin/proteasome‐mediated degradation of cellular FLICE‐inhibitory protein (c‐FLIP).15